Avoiding MRI-Interference with Co-existing Systems

• US 20130053678A1
• Filed: 08/31/2011
• Published: 02/28/2013
• Est. Priority Date: 08/31/2011
• Status: Abandoned Application

• Current Assignee: InSightec Ltd.
• Original Assignee: InSightec Ltd.
• Inventors: Vitek, Shuki, Assif, Benny, Greenberg, Adi
• Application Number:
  US13/222,086
• Publication Number:
  US 20130053678A1
• Time in Patent Office: Days
• US Class Current: 600/411
• CPC Class Codes: A61B 2017/22007 Cavitation or pseudocavitation, i.e. creation of gas bubbles generating a secondary shock wave when collapsing
• CPC Class Codes: A61B 2090/374 NMR or MRI
• CPC Class Codes: A61B 2090/378 using ultrasound
• CPC Class Codes: A61B 5/055 involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
• CPC Class Codes: A61B 8/0808 for diagnosis of the brain
• CPC Class Codes: A61N 2007/0078 with multiple treatment transducers
• CPC Class Codes: A61N 7/02 Localised ultrasound hyperthermia hyperthermia in general A61F7/00

Abstract

MRI interference with a co-existing treatment system may be reduced or avoided by carrying out RF-sensitive operations of the treatment system only when gradient field activity of the MRI system is suppressed.

Claims

1. A method of performing treatment of an anatomic region in conjunction with magnetic resonance (MR) imaging of the region, the treatment comprising at least one radio-frequency-sensitive (RF-sensitive) operation, the method comprising the steps of:

during an MR imaging operation, temporarily suppressing gradient field activity; and

carrying out the RF-sensitive operation only when the gradient field activity is suppressed.

2. The method of claim 1 wherein the gradient-field-activity suppression corresponds to substantially zero gradient fields.

3. The method of claim 1 wherein the gradient-field-activity suppression corresponds to substantially constant gradient fields.

4. The method of claim 1 further comprising signaling, by an MR imaging apparatus, onset of the gradient-field-activity suppression.

5. The method of claim 1 wherein the MR imaging conforms to a pulse sequence specifying an onset time of the gradient-field-activity suppression, and onset of the RF-sensitive operation is based on the onset time.

6. The method of claim 5 wherein the gradient field activity is suppressed periodically during the pulse sequence.

7. The method of claim 1 wherein the MR imaging conforms to a pulse sequence having a repetition time period associated therewith, the method further comprising determining when the repetition time period ends.

8. The method of claim 7 further comprising carrying out the RF-sensitive operation after the repetition time period has ended, and triggering a new repetition time period after completion of the RF-sensitive operation.

9. The method of claim 1 further comprising synchronizing the treatment and the MR imaging with a synchronization signal.

10. The method of claim 1 wherein the treatment and the MR imaging are synchronized to a common clock.

11. The method of claim 1, wherein the RF-sensitive operation is an ultrasound operation.

12. The method of claim 11 wherein the RF-sensitive ultrasound operation comprises at least one of measuring cavitation, measuring acoustic reflections, or ultrasound imaging.

13. The method of claim 1 wherein non-RF-sensitive treatment operations are carried out while gradient fields are active.

14. A controller for synchronizing an MRI apparatus with a treatment system performing operations at least one of which is RF-sensitive, the controller comprising:

a module for receiving information about an MRI pulse sequence specifying time intervals wherein gradient fields are suppressed; and

a module for initiating the RF-sensitive treatment operation at the onset of the gradient-field suppression based on the information.

15. A system for performing treatment of an anatomic region in conjunction with MR imaging of the region, the treatment comprising at least one RF-sensitive operation, the system comprising:

an MRI apparatus for imaging the anatomic region, the imaging comprising gradient field activity; and

a treatment controller in communication with the MRI apparatus, the treatment controller causing the RF-sensitive operation to be carried out only when the gradient field activity is suppressed.

16. The system of claim 15 further comprising an MRI controller for operating the MRI apparatus in accordance with a pulse sequence that includes time intervals where the gradient field activity is suppressed, and signaling the time intervals to the treatment controller so as to cause performance of the RF-sensitive operation during the time intervals.

17. The system of claim 15 further comprising an MRI controller for operating the MRI apparatus in accordance with a pulse sequence, wherein the treatment controller causes performance of the RF-sensitive operation in response to an end of the pulse sequence, and triggers repetition of the pulse sequence after completion of the RF-sensitive operation.

18. The system of claim 15 further comprising a treatment apparatus for performing the treatment.

19. The system of claim 18 wherein the treatment apparatus comprises an ultrasound transducer.

20. An MRI system operable in conjunction with a treatment system for performing MR imaging of an anatomic region in conjunction with treatment of the region, the treatment comprising at least one RF-sensitive operation, the MRI system comprising:

an MRI apparatus for imaging the anatomic region, the imaging comprising gradient field activity; and

an MRI controller for operating the MRI apparatus in accordance with a pulse sequence that includes time intervals where the gradient field activity is suppressed, and signaling the time intervals to the treatment system so as to cause performance of the RF-sensitive operation during the time intervals.

21. A treatment system operable in conjunction with an MRI system for performing treatment of an anatomic region in conjunction with MR imaging of the region, the treatment comprising at least one RF-sensitive operation, the treatment system comprising:

a treatment apparatus for performing the treatment; and

a treatment controller for causing performance of the RF-sensitive operation in response to an end of an MRI pulse sequence comprising gradient field activity, and triggering repetition of the pulse sequence after completion of the RF-sensitive operation

22. The treatment system of claim 21, wherein the treatment apparatus comprises an ultrasound transducer.